MNK

6 More Pharma Companies Selling Overpriced Drugs

By James Brumley, InvestorPlace Feature Writer
Overpriced drugs are more common with the pharma industry than most realize, and these names are the worst offenders.

Biggest Movers in Manufacturing Stocks Now – ADXS PLOW AMKR SODA

By Portfolio Grader
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

3 Stocks Under Investigation (VRX, MNK, SUNE)

By Wayne Duggan, InvestorPlace Contributor
Investors seem to be assuming the worst when it comes to the ongoing investigations of VRX, MNK and SUNE.

Why Caesars Entertainment Corp (CZR), LinkedIn Corp (LNKD) and Mallinckrodt PLC (MNK) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer
Mallinckrodt (MNK), Caesars Entertainment Corp (CZR) and LinkedIn (LNKD) were suspiciously left out of Wednesday's market-wide, post-Yellen-comment advance. Here's the deal.

7 Big Pharma & Biotech Stocks to Sell or Short

By Anthony Mirhaydari, InvestorPlace Market Strategist
Biotech stocks and Big Pharma look vulnerable to a toppy market. While these seven stocks aren't bad long-term bets, you may want to take some profits.

10 CEOs That Could Be Toast Before 2017

By John Divine, InvestorPlace Assistant Editor
No one on this list of the world's worst CEOs should be too shocked if they're canned before the next new year wheels around.

U.S. Corporate Tax Code Hinders Economy

By Lawrence Meyers, InvestorPlace Contributor
Corporate tax inversions are a boon for companies, but tax cuts are even better.

Valeant Pt. II? Mallinckrodt PLC (MNK) Stock Plunges on Citron Tweet

By John Divine, InvestorPlace Assistant Editor
Citron Research issued an ominous tweet on Monday that could have grave consequences for the Mallinckrodt (MNK) stock price. Is this Valeant part 2?

10 Best Stocks in the S&P 500

By Jeff Reeves
Some of the biggest names in the S&P 500 with market caps in the tens of billions have tacked on as much as 40% in the first three months of the year -- and several have more upside to come.

3 Best Stocks to Keep Your Portfolio Healthy

By Louis Navellier, Editor, Growth Investor
Healthcare, health insurance and pharma stocks are great places to put your money this month.

Mallinckrodt Stock – Buy MNK for Its Pharma Prowess

By Louis Navellier, Editor, Growth Investor
Mallinckrodt PLC (NYSE:MNK) has been around for 175 years and has been a part of some of the biggest medical scientific breakthroughs.
Load More